₹3,326.10
₹-47.00 (-1.39%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹3,449 Cr
P/E
42.55
ROE
20.31%
ROCE
21.46%
About Kwality Pharmaceuticals Ltd
Kwality Pharmaceuticals is engaged in the business of manufacturers, buyers and sellers of and dealers in all kind of drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations.
Founded
1983
CEO
Aditya Arora
Employees
997
HQ
Amritsar, Punjab
About Kwality Pharmaceuticals Ltd
Kwality Pharmaceuticals is engaged in the business of manufacturers, buyers and sellers of and dealers in all kind of drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations.
Founded:1983
CEO:Aditya Arora
Employees:997
HQ:Amritsar, Punjab
Finished Products
1Sales
₹677.37CrRaw Materials
1Raw Materials Consumed
₹319.22Cr2Purchase of Stock-in-Trade
₹16.76CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹3,744
52W Low
₹1,561
Volume33.08K
Avg VolumeN/A
Beta0.67
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
42.55x
Valuation
P/B Ratio
10.43x
Valuation
EPS
₹78.11
Valuation
Dividend Yield
0.00%
Valuation
ROE
20.31%
Profitability
ROCE
21.46%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
47.2%
International
52.8%
Export52.8%
Domestic47.2%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.39x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
17.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.